Stroke related circadian rhythm disorder sleep wake disorder
Conditions
Interventions
Drug group:On the basis of sleep hygiene education and behavioral management, the melatonin receptor agonist agomelatine was orally administered at a dose of 25 mg/d, while the medication group was gi
Meridian flow group:On the basis of sleep hygiene education and behavior management, the two groups were treated with melatonin receptor agonist(25mg/d), the Ziwu Liuzhu group was given meridian injec
Sponsors
Zhongnan Hospital of Wuhan University
Eligibility
Sex/Gender
All
Age
35 Years to 70 Years
Inclusion criteria
Inclusion criteria: (1)Meeting the diagnostic criteria for stroke and circadian rhythm disorder of sleep; (2)Aged between 35 and 70 years old without cognitive impairment and no cognitive dysfunction, able to fully understand the scale and cooperate with treatment; (3)Understanding and agreeing to join the study and signing a written informed consent form; (4)No allergic reactions to treatment drugs.
Exclusion criteria
Exclusion criteria: (1) Patients with severe hepatic and renal insufficiency; (2) People with severe cognitive and communication disabilities and those with visual and hearing disabilities; (3) Combined with serious mental illness and other sleep disorders; (4)the skin at the acupoint is damaged; (5)People who have taken sleeping pills or antidepressant anxiety drugs in the past; (6)Patients with peripheral nerve and muscle system disease; (7) Pregnancy, lactation, pregnancy preparation in the near future.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sleep quality; Sleep efficiency \ wake times \ sleep latency \ total sleep time; | — |
Secondary
| Measure | Time frame |
|---|---|
| 12.5%;HAMA score;HAMD score; | — |
Countries
China
Contacts
Public ContactTian Jun
Zhongnan Hospital of Wuhan University
Outcome results
None listed